Saltar a la navegació principal
Saltar a la cerca
Vés al contingut principal
Ordenar per
Keyphrases
Ventilator-associated Pneumonia
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
C-reactive Protein
25%
Procalcitonin
25%
Clinical Pulmonary Infection Score
25%
Pneumonia Patients
25%
Prognostic Value
12%
Critically Ill Patients
12%
Multicenter Cohort Study
12%
Critically Ill
12%
Area under the Receiver Operating Characteristic Curve
12%
Diagnostic Accuracy
12%
Systemic Infection
12%
Prognostic Accuracy
12%
Scoring System
12%
Patients at Risk
12%
Discriminative Accuracy
12%
Tracheal Aspirate
12%
Sepsis-related Organ Failure Assessment
12%
Deceased Patients
12%
Intensive Care Unit Patients
12%
Nursing and Health Professions
Ventilator-Associated Pneumonia
100%
Urokinase Receptor
100%
Area under the Curve
37%
Procalcitonin
25%
C Reactive Protein
25%
Lung Infection
25%
Intensive Care Unit
12%
Receiver Operating Characteristic
12%
Sequential Organ Failure Assessment Score
12%
Prospective Cohort Study
12%
Sepsis
12%
Biological Marker
12%
Scoring System
12%
Diagnostic Accuracy
12%
Tracheal Aspiration Procedure
12%
Medicine and Dentistry
Ventilator-Associated Pneumonia
100%
Urokinase Receptor
100%
C Reactive Protein
25%
Lung Infection
25%
Procalcitonin
25%
Biological Marker
12%
Sepsis
12%
Prospective Cohort Study
12%
SOFA Score
12%
Diagnostic Accuracy
12%
Scoring System
12%
Tracheal Aspiration Procedure
12%
Intensive Care Unit
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ventilator Associated Pneumonia
100%
Urokinase Receptor
100%
Sepsis
25%
C Reactive Protein
25%
Procalcitonin
25%
Lung Infection
25%
Prospective Cohort Study
12%
Biological Marker
12%